Form 4 for NPCE NeuroPace Inc
Accepted 2025-03-20 00:00:00 ET · period of report 2025-03-10 · accession 0001415889-25-008695 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-20 | 2025-03-10 | NPCE | Kuhn Rebecca | CFO | A - Grant | $0.00 | +11.7K | 136.6K | +9% | $0 |
| D | 2025-03-20 | 2025-03-10 | NPCE | Kuhn Rebecca | CFO | A - Grant | $0.00 | +19.9K | 19.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-10 | A | A | 11,700 | $0.00 | 136,595 | D | — | — | (F1) Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon settlement. 25% of the RSUs vest on March 3, 2026 and the remaining RSUs vest in twelve (12) equal quarterly installments thereafter. |
| 2 | Derivative | Stock Option (Rt to Buy) | 2025-03-10 | A | A | 19,850 | $0.00 | 19,850 | D | $10.04 · — to 2035-03-09 | 19,850 Common Stock | (F2) 25% of the shares subject to the option vest on March 3, 2026. The remaining shares subject to the option vest in thirty six (36) equal consecutive monthly installments thereafter. |